Anixa Biosciences Announces Opening of Enrollment for Keytruda Arm in Ongoing Breast Cancer Vaccine Clinical Trial
SAN JOSE, Calif., Aug. 7, 2023. Anixa Biosciences, Inc. ( " Anixa " or the " Company " ), a biotechnology company focused on the treatment and prevention of cancer, today announced that its partner, Cleveland Clinic, has begun enrolling subjects in a... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - August 7, 2023 Category: Pharmaceuticals Source Type: clinical trials

First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients
Conditions:   Esophageal Cancer;   Pancreas Cancer;   Ovarian Cancer;   Liver Cancer Intervention:   Biological: IL15-transpresenting WT1-targeted Dendritic Cell Vaccine Sponsors:   University Hospital, Antwerp;   Kom Op Tegen Kanker;   Stichting tegen Kanker Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials

A Chatbot Intervention for Reducing HPV Vaccine Hesitancy
Conditions:   Cervical Cancer;   Anal Cancer;   Penile Cancer Interventions:   Behavioral: Personalized Chatbot Intervention;   Behavioral: Non-Personalized Chatbot Intervention;   Behavioral: No Chatbot Control Sponsor:   University of Maryland, College Park Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials